FOCLIVIA sol inj 7.5 µg 0.5 ml PFS 1 pce

7680661560018 CH-66156 J07BB02 08.08.
FOCLIVIA sol inj 7.5 µg 0.5 ml PFS 1 pce
FOCLIVIA sol inj 7.5 µg 0.5 ml PFS 1 pce
FOCLIVIA sol inj 7.5 µg 0.5 ml PFS 1 pce
1 / 3
google

Details

Product number
6615601
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
haemagglutininum influenzae A (H5N1) 7.5 µg et neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14), adjuvans MF59C.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.9 mg, kalium 0.05 mg.

Articles (1)

Foclivia, Injektionssuspension in einer Fertigspritze
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
09/12/2025
Professional SmPC
Français
09/12/2025
Professional SmPC
Italien
09/12/2025

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H5N1)
7.5 UG Substance Wirkstoff (Principe actif)
neuraminidasum inactivatum
- Substance Wirkstoff (Principe actif)
squalenum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
sorbitani trioleas
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
calcii chloridum dihydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.9 MG Substance HBESI
kalium
0.05 MG Substance HBESI

Authorization holder

Vifor (International) Inc.

9014 St. Gallen

Authorization information

Swissmedic authorization number
66156
Drug name
Foclivia, Injektionssuspension in einer Fertigspritze
Galenic form
INJFS
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
20/04/2018
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
Pandemischer Influenza Impfstoff

Packaging details

Description (FR)
FOCLIVIA sol inj 7.5 µg 0.5 ml PFS 1 pce
Description (DE)
FOCLIVIA Inj Lös 7.5 µg 0.5 ml PFS 1 Stk
Market launch
20/04/2018
Narcotic (BTM)
No

Other packaging sizes

FOCLIVIA 7.5 µg susp inj ser prérempl 10 pce
10 FESP
View
Buy us a coffee Explore the data